0001209191-14-077827.txt : 20141223 0001209191-14-077827.hdr.sgml : 20141223 20141223180603 ACCESSION NUMBER: 0001209191-14-077827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141222 FILED AS OF DATE: 20141223 DATE AS OF CHANGE: 20141223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141307925 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-12-22 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2014-12-22 4 M 0 4800 10.41 A 343695 D Common Stock 2014-12-22 4 M 0 1300 17.16 A 344995 D Common Stock 2014-12-22 4 M 0 4400 35.64 A 349395 D Common Stock 2014-12-22 4 S 0 3530 116.56 D 345865 D Common Stock 2014-12-22 4 S 0 4570 117.44 D 341295 D Common Stock 2014-12-22 4 S 0 900 118.22 D 340395 D Common Stock 2014-12-22 4 S 0 500 119.33 D 339895 D Common Stock 2014-12-22 4 S 0 600 120.78 D 339295 D Common Stock 2014-12-22 4 S 0 400 121.67 D 338895 D Common Stock 13286 I 401(k) Common Stock 172589 I Common Stock held in trust Stock Option (right to buy) 10.41 2014-12-22 4 M 0 4800 0.00 D 2015-02-02 Common Stock 4800 24188 D Stock Option (right to buy) 17.16 2014-12-22 4 M 0 1300 0.00 D 2015-07-19 Common Stock 1300 38200 D Stock Option (right to buy) 35.64 2014-12-22 4 M 0 4400 0.00 D 2016-02-01 Common Stock 4400 551600 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $116.56 (range $116.00 to $116.97). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $117.44 (range $117.00 to $117.98). Open market sales reported on this line occurred at a weighted average price of $118.22 (range $118.06 to $118.63). Open market sales reported on this line occurred at a weighted average price of $119.33 (range $119.12 to $119.39). Open market sales reported on this line occurred at a weighted average price of $120.78 (range $120.15 to $121.11). Open market sales reported on this line occurred at a weighted average price of $121.67 (range $121.64 to $121.76). Common stock held in grantor retained annuity trusts. Fully vested. Omar White, Attorney-In-Fact 2014-12-23